Etiopathogenesis of inflammatory bowel disease: today and tomorrow

Curr Opin Gastroenterol. 2017 Jul;33(4):222-229. doi: 10.1097/MOG.0000000000000364.

Abstract

Purpose of review: Crohn's disease and ulcerative colitis, the two major forms of inflammatory bowel disease (IBD), represent chronic diseases of unknown cause, and they are regarded as prototypical complex diseases. Despite all the recent advances, a complete appreciation of the pathogenesis of IBD is still limited. In this review, we present recent information contributing to a better understanding of mechanisms underlying IBD.

Recent findings: Here, we attempt to highlight novel environmental triggers, data on the gut microbiota, its interaction with the host, and the potential influence of diet and food components. We discuss recent findings on defective signaling pathways and the potential effects on the immune response, and we present new data on epigenetic changes, inflammasome, and damage-associated molecular patterns associated with IBD.

Summary: The continuing identification of several epigenetic, transcriptomic, proteomic, and metabolomic alterations in patients with IBD reflects the complex nature of the disease and suggests the need for innovative approaches such as systems biology for identifying novel relevant targets in IBD.

Publication types

  • Review

MeSH terms

  • Diet, Western / adverse effects*
  • Epigenomics
  • Gastrointestinal Microbiome / immunology*
  • Gene-Environment Interaction
  • Genetic Predisposition to Disease
  • Humans
  • Immunity, Innate / genetics
  • Immunity, Innate / immunology*
  • Inflammatory Bowel Diseases / etiology
  • Inflammatory Bowel Diseases / genetics
  • Inflammatory Bowel Diseases / immunology
  • Inflammatory Bowel Diseases / physiopathology*
  • Metabolomics
  • Proteomics
  • Risk Factors
  • Systems Biology